- You are here: Home
- Services
- In Vitro DMPK Services
- In Vitro Drug Distribution Services
- Microsomal Binding Assay
Services
-
Cell Services
- Cell Line Authentication
- Cell Surface Marker Validation Service
-
Cell Line Testing and Assays
- Toxicology Assay
- Drug-Resistant Cell Models
- Cell Viability Assays
- Cell Proliferation Assays
- Cell Migration Assays
- Soft Agar Colony Formation Assay Service
- SRB Assay
- Cell Apoptosis Assays
- Cell Cycle Assays
- Cell Angiogenesis Assays
- DNA/RNA Extraction
- Custom Cell & Tissue Lysate Service
- Cellular Phosphorylation Assays
- Stability Testing
- Sterility Testing
- Endotoxin Detection and Removal
- Phagocytosis Assays
- Cell-Based Screening and Profiling Services
- 3D-Based Services
- Custom Cell Services
- Cell-based LNP Evaluation
-
Stem Cell Research
- iPSC Generation
- iPSC Characterization
-
iPSC Differentiation
- Neural Stem Cells Differentiation Service from iPSC
- Astrocyte Differentiation Service from iPSC
- Retinal Pigment Epithelium (RPE) Differentiation Service from iPSC
- Cardiomyocyte Differentiation Service from iPSC
- T Cell, NK Cell Differentiation Service from iPSC
- Hepatocyte Differentiation Service from iPSC
- Beta Cell Differentiation Service from iPSC
- Brain Organoid Differentiation Service from iPSC
- Cardiac Organoid Differentiation Service from iPSC
- Kidney Organoid Differentiation Service from iPSC
- GABAnergic Neuron Differentiation Service from iPSC
- Undifferentiated iPSC Detection
- iPSC Gene Editing
- iPSC Expanding Service
- MSC Services
- Stem Cell Assay Development and Screening
- Cell Immortalization
-
ISH/FISH Services
- In Situ Hybridization (ISH) & RNAscope Service
- Fluorescent In Situ Hybridization
- FISH Probe Design, Synthesis and Testing Service
-
FISH Applications
- Multicolor FISH (M-FISH) Analysis
- Chromosome Analysis of ES and iPS Cells
- RNA FISH in Plant Service
- Mouse Model and PDX Analysis (FISH)
- Cell Transplantation Analysis (FISH)
- In Situ Detection of CAR-T Cells & Oncolytic Viruses
- CAR-T/CAR-NK Target Assessment Service (ISH)
- ImmunoFISH Analysis (FISH+IHC)
- Splice Variant Analysis (FISH)
- Telomere Length Analysis (Q-FISH)
- Telomere Length Analysis (qPCR assay)
- FISH Analysis of Microorganisms
- Neoplasms FISH Analysis
- CARD-FISH for Environmental Microorganisms (FISH)
- FISH Quality Control Services
- QuantiGene Plex Assay
- Circulating Tumor Cell (CTC) FISH
- mtRNA Analysis (FISH)
- In Situ Detection of Chemokines/Cytokines
- In Situ Detection of Virus
- Transgene Mapping (FISH)
- Transgene Mapping (Locus Amplification & Sequencing)
- Stable Cell Line Genetic Stability Testing
- Genetic Stability Testing (Locus Amplification & Sequencing + ddPCR)
- Clonality Analysis Service (FISH)
- Karyotyping (G-banded) Service
- Animal Chromosome Analysis (G-banded) Service
- AAV Biodistribution Analysis (RNA ISH)
- Molecular Karyotyping (aCGH)
- Droplet Digital PCR (ddPCR) Service
- Digital ISH Image Quantification and Statistical Analysis
- SCE (Sister Chromatid Exchange) Analysis
- Biosample Services
- Histology Services
- Exosome Research Services
- In Vitro DMPK Services
-
In Vivo DMPK Services
- Pharmacokinetic and Toxicokinetic
- PK/PD Biomarker Analysis
- Bioavailability and Bioequivalence
- Bioanalytical Package
- Metabolite Profiling and Identification
- In Vivo Toxicity Study
- Mass Balance, Excretion and Expired Air Collection
- Administration Routes and Biofluid Sampling
- Quantitative Tissue Distribution
- Target Tissue Exposure
- In Vivo Blood-Brain-Barrier Assay
- Drug Toxicity Services
Microsomal Binding Assay
Creative Bioarray provides Microsomal Binding Assay to help customers accurately understand the relationship between in vitro drug metabolism data and in vivo pharmacokinetics, predicting hepatic clearance and drug-drug interactions.
Why do we need Microsomal Binding Assay?
- In vitro metabolism tests with non-specific microsomal binding can considerably impact the measured metabolic kinetics and make accurate clearance prediction difficult. Only unbound substrates can freely interact with drug-metabolizing enzymes in microsomes.
- Elucidating the extent of microsomal binding can provide a better understanding of the relationship between in vitro drug metabolism data and in vivo pharmacokinetics. Furthermore, it can also be used to study hepatic clearance and drug-drug interactions.
- The Microsomal Binding assay using logP for basic compounds and logD7.4 for acidic and neutral compounds is the best method to predict the hepatic clearance of drugs and drug-drug interactions. This model can estimate the extent of binding to any given concentration of microsomes purely in terms of lipophilicity and ionization.
Brief Protocol
- Microsomal Incubations
1) The liver microsomes were incubated with the compounds in phosphate buffer (pH 7.4) at a constant temperature of 37°C.
2) After this equilibration period, the metabolic reactions were initiated by the addition of β-NADPH solution.
3) An amount of the above mixture was taken and quenched at different consecutive time points by adding methanol.
4) The quenched liquid was centrifuged, the precipitate removed, and quantified using HPLC/MS.
5) The kinetic data were analyzed using a linear fit of the natural logarithm of the ratio of the compound peak area to the internal standard peak area against time. Furthermore, calculate the CLint value.
- Measurement of Microsomal Binding
1) The extent of binding of compounds to microsomes was determined using equilibrium dialysis.
2) Hepatic microsomes were added to one side of the dialysis chamber to suspend them in a pH7.4 phosphate buffer, and DMSO was added. A pH 7.4 phosphate buffer was used as the dialysis solution on the other side of the dialysis chamber.
3) After sealing and rotating in a 37°C water bath for 18 h, DMSO was added to the dialysate.
4) Quantification of the substances in both chambers was done using HPLC/MS.
- Measurement of LogD7.4
Partitioning of compounds between 1-octanol and 0.02 M phosphate buffer, pH 7.4, at 20°C was determined using a standard shake flask method. HPLC analyzed samples with MS quantitation of both layers of the partition mixture.
- Measuring fuinc
The microsomal binding assessment should ideally be performed at the same concentrations as the microsomal stability assay. However, if this is impractical, then the equation described by Austin et al.(2002) can be used to convert from the fraction unbound at one microsomal protein concentration to the fraction unbound at another.
Where
fuinc: the fraction of unbound drug in incubation
fu2: the free fraction at a second microsomal concentration;
fu1: the free fraction at a first microsomal concentration;
C1: first microsomal concentration;
C2: the second microsomal concentration.
Quotation and ordering
If you have any special needs or questions regarding our services, please feel free to contact us. We look forward to cooperating with you in the future.
References
- Austin, Rupert P., et al. "The influence of non-specific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties." Drug Metabolism and Disposition 30.12 (2002): 1497-1503.
- Watanabe, Reiko, et al. "Predicting fraction unbound in human plasma from chemical structure: improved accuracy in the low value ranges." Molecular pharmaceutics 15.11 (2018): 5302-5311.
Explore Other Options
For research use only. Not for any other purpose.